Skip to main content
Top
Published in: European Journal of Nutrition 7/2020

01-10-2020 | LETTER TO THE EDITOR

The ‘Seal’ of Sir Shackleton

Authors: E. Cognat, M. Lilamand, R. Nabbout, A. Raynaud-Simon, C. Paquet

Published in: European Journal of Nutrition | Issue 7/2020

Login to get access

Excerpt

On 5 December 1914, Sir Ernest Shackleton and his 27-man-crew departed South Georgia aboard the ‘Endurance’ with the purpose to be the first expedition to cross the Antarctic continent from sea to sea. Unfortunately, ice packs rapidly entangled the ship which was eventually crushed. After enduring a brutal 10-month journey on the ice floe, Shackleton’s entire crew was rescued on 30 August 1916. …
Literature
2.
go back to reference Nabbout R, Copioli C, Chipaux M et al (2011) Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia 52:e54–57CrossRef Nabbout R, Copioli C, Chipaux M et al (2011) Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia 52:e54–57CrossRef
3.
go back to reference Lilamand M, Porte B, Cognat E et al (2020) Are ketogenic diets promising for Alzheimer’s disease? A translational review. Alzheimers Res Ther 12:42CrossRef Lilamand M, Porte B, Cognat E et al (2020) Are ketogenic diets promising for Alzheimer’s disease? A translational review. Alzheimers Res Ther 12:42CrossRef
4.
go back to reference Zhao M, Huang X, Cheng X et al (2017) Ketogenic diet improves the spatial memory impairment caused by exposure to hypobaric hypoxia through increased acetylation of histones in rats. PLoS ONE 12:e0174477CrossRef Zhao M, Huang X, Cheng X et al (2017) Ketogenic diet improves the spatial memory impairment caused by exposure to hypobaric hypoxia through increased acetylation of histones in rats. PLoS ONE 12:e0174477CrossRef
5.
go back to reference Brietzke E, Mansur RB, Subramaniapillai M et al (2018) Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments. Neurosci Biobehav Rev 94:11–16CrossRef Brietzke E, Mansur RB, Subramaniapillai M et al (2018) Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments. Neurosci Biobehav Rev 94:11–16CrossRef
Metadata
Title
The ‘Seal’ of Sir Shackleton
Authors
E. Cognat
M. Lilamand
R. Nabbout
A. Raynaud-Simon
C. Paquet
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 7/2020
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02349-3

Other articles of this Issue 7/2020

European Journal of Nutrition 7/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.